Quick Takeaways
- EVOK - Evoke Pharma Inc has 14 insiders with reported activity on this page.
- Net insider value flow over the last year: -$95,885.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 14 Insiders of Evoke Pharma Inc
- Symbol
- EVOK on Nasdaq
- Location
- Solana Beach, CA
What Changed
- Buy value: ; sell value: $95,885.
- Net share flow: -9,000.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$95,885.
Buys
$0
Shares: 0
Insiders: 0
Sells
$95,885
Shares: 9,000
Insiders: 1
Net
-$95,885
Shares: -9,000
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 9,000 | $0 | $95,885 | -$95,885 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Evoke Pharma Inc executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Roger M. Klein | 10%+ Owner | $1,640,303 | -$95,885 | -5.5% | Filing P/S | 06 Nov 2025 |
| Mark Kowieski | Chief Financial Officer | $0 | Mixed | 16 Dec 2025 | ||
| Nantahala Capital Management, LLC | 10%+ Owner | $0 | Mixed | 17 Dec 2025 | ||
| Todd C. Brady | Director | $0 | Mixed | 16 Dec 2025 | ||
| Marilyn R. Carlson | Chief Medical Officer | $0 | Mixed | 16 Dec 2025 | ||
| Malcolm R. Hill | Director | $0 | Mixed | 16 Dec 2025 | ||
| Matthew J. D'Onofrio | Chief Executive Officer, Director | $0 | Mixed | 16 Dec 2025 | ||
| Cam L. Garner | Director | $0 | Mixed | 16 Dec 2025 | ||
| WIDDER KENNETH J | Director | Mixed | 17 Dec 2025 | |||
| Benjamin C. Smeal | Director | Mixed | 17 Dec 2025 | |||
| Ann D. Rhoads | Director | Mixed | 05 May 2021 | |||
| Greg Pyszczymuka | Director | Mixed | 17 Dec 2025 | |||
| David A. Gonyer | CEO, Director | Mixed | 08 Feb 2023 | |||
| Vickie S. Reed | Director | Mixed | 17 Dec 2025 |
Top shareholders of Evoke Pharma Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Roger M. Klein |
3/4/5
13D/G
|
10%+ Owner · Klein Roger M. |
10%
from 13D/G
|
154,000
|
$1,640,303 | -$95,885 | 06 Nov 2025 | |
| Laurence W. Lytton |
13D/G
|
Lytton, Laurence W. |
3.9%
|
61,274
|
$158,087 | $0 | 31 Mar 2025 | |
| Bleichroeder LP |
13D/G
|
— |
10%
|
158,058
|
$63,223 | $0 | 24 Mar 2025 | |
| MORGAN STANLEY |
13D/G
|
— |
0%
|
31
|
$331 | -$1,749,814 | 30 Nov 2025 | |
| Ann D. Rhoads |
3/4/5
|
Director |
—
class O/S missing
|
61,750
|
— | — | 05 May 2021 | |
| David A. Gonyer |
3/4/5
|
CEO, Director |
—
class O/S missing
|
30,000
|
— | — | 08 Feb 2023 |
Recent Insider Transactions by Companies or Individuals for Evoke Pharma Inc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | EVOK | Common Stock | Other | -100% | -148,153 | 0 | 17 Dec 2025 | See Footnote | ||
| Nantahala Capital Management, LLC | EVOK | Amended Series C Common Stock Purchase Warrants | Other | -100% | -250,627 | 0 | 17 Dec 2025 | See Footnote | ||
| Nantahala Capital Management, LLC | EVOK | Amended Series A Common Stock Purchase Warrants | Other | -100% | -158,531 | 0 | 17 Dec 2025 | See Footnote | ||
| Nantahala Capital Management, LLC | EVOK | Series C Common Stock Purchase Warrants | Other | -100% | -117,019 | 0 | 17 Dec 2025 | See Footnote | ||
| Nantahala Capital Management, LLC | EVOK | Series A Common Stock Purchase Warrants | Other | -100% | -117,019 | 0 | 17 Dec 2025 | See Footnote | ||
| Nantahala Capital Management, LLC | EVOK | Prefunded Warrants | Other | -100% | -433,962 | 0 | 17 Dec 2025 | See Footnote | ||
| Greg Pyszczymuka | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -6,988 | 0 | 17 Dec 2025 | Direct | ||
| Benjamin C. Smeal | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -6,958 | 0 | 17 Dec 2025 | Direct | ||
| Marilyn R. Carlson | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -28,291 | 0 | 17 Dec 2025 | Direct | ||
| Cam L. Garner | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -11,520 | 0 | 17 Dec 2025 | Direct | ||
| Malcolm R. Hill | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -8,269 | 0 | 17 Dec 2025 | Direct | ||
| Mark Kowieski | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -30,291 | 0 | 17 Dec 2025 | Direct | ||
| Widder Kenneth J | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -8,207 | 0 | 17 Dec 2025 | Direct | ||
| Todd C. Brady | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -8,238 | 0 | 17 Dec 2025 | Direct | ||
| Vickie S. Reed | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -8,333 | 0 | 17 Dec 2025 | Direct | ||
| Matthew J. D'Onofrio | EVOK | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -134,840 | 0 | 17 Dec 2025 | Direct | ||
| Marilyn R. Carlson | EVOK | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -360 | 0 | 16 Dec 2025 | Direct | ||
| Cam L. Garner | EVOK | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -2,330 | 0 | 16 Dec 2025 | By Garner Investments, L.L.C. | ||
| Malcolm R. Hill | EVOK | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -133 | 0 | 16 Dec 2025 | Direct | ||
| Mark Kowieski | EVOK | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -11,815 | 0 | 16 Dec 2025 | Direct | ||
| Todd C. Brady | EVOK | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -27 | 0 | 16 Dec 2025 | Direct | ||
| Matthew J. D'Onofrio | EVOK | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -15,509 | 0 | 16 Dec 2025 | Direct | ||
| Roger M. Klein | EVOK | Common Stock | Sale | -3.1% | $42,600 | $10.65 | -4,000 | 125,000 | 06 Nov 2025 | By Krieger Charitable Trust |
| Roger M. Klein | EVOK | Common Stock | Sale | -14.7% | $53,285 | $10.66 | -5,000 | 29,000 | 06 Nov 2025 | By IRA |
| Todd C. Brady | EVOK | Stock Option (Right to Buy) | Award | 16.8% | 1,187 | 8,238 | 21 May 2025 | Direct | ||
| Malcolm R. Hill | EVOK | Stock Option (Right to Buy) | Award | 17.3% | 1,218 | 8,269 | 21 May 2025 | Direct | ||
| Cam L. Garner | EVOK | Stock Option (Right to Buy) | Award | 12.6% | 1,291 | 11,520 | 21 May 2025 | Direct | ||
| Vickie S. Reed | EVOK | Stock Option (Right to Buy) | Award | 17.6% | 1,250 | 8,333 | 21 May 2025 | Direct | ||
| Widder Kenneth J | EVOK | Stock Option (Right to Buy) | Award | 16.9% | 1,187 | 8,207 | 21 May 2025 | Direct | ||
| Benjamin C. Smeal | EVOK | Stock Option (Right to Buy) | Award | 19.3% | 1,125 | 6,958 | 21 May 2025 | Direct | ||
| Greg Pyszczymuka | EVOK | Stock Option (Right to Buy) | Award | 19.8% | 1,155 | 6,988 | 21 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.